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0014-5793  2012 Federation of European BiochemicLipids are essential eukaryotic cellular constituents. Lipid metabolism has a strong impact on cell
physiology, and despite good progress in this area, many important basic questions remain unan-
swered concerning the functional diversity of lipid species and on the mechanisms that cells employ
to sense and adjust their lipid composition. Combining convenient experimental tractability, a large
degree of conservation of metabolic pathways with other eukaryotes and the relative simplicity of
its genome, proteome and lipidome, yeast represents the most advantageous model organism for
studying lipid homeostasis and function. In this review we will focus on the importance of yeast
as a model organism and some of the innovative advantages for the lipid research ﬁeld.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction – the study of lipid homeostasis and function –
approaches and applications
Lipids are essential eukaryotic cellular constituents. Although
their main functions have long been attributed as solely structural
components, their role as vital molecules has been increasingly
recognized. Today, lipids are considered as important dynamic
molecules that play vital roles which extend beyond their roles
in membrane structure [1,2]. Therefore the impact of lipids in cell
biology has caught the attention of investigators from many differ-
ent areas, pushing the lipid research ﬁeld forward. The importance
of understanding how lipid homeostasis is maintained has gained
much prominence, as new analytical technologies emerge, gener-
ating a vast amount of information from studies in model systems
and in humans [3,4].
Given their fundamental role in cell biology, it is not surprising
that complex mechanisms are employed to robustly maintain lipid
homeostasis. The eukaryotic genomes dedicate a considerable pro-
portion to the coding of numerous genes required for lipid metab-
olism and lipid homeostasis [5]. But genes and transcripts do not
always predict the precise levels of active proteins/enzymes and,
to fully understand lipid function and homeostasis, it is necessary
not only to be able to characterize the genes, proteins and,zman).
al Societies. Published by Elsevierobviously, lipids involved in the scenario, but also to be able to de-
scribe the regulatory system as a whole.
The study of lipids in cell biology (‘‘lipidology’’) emerged in the
early 1960’s with the ﬁrst attempts to describe and understand li-
pid composition of cells [6]. The traditional approaches for the
study of cellular lipids relied on analytical techniques with low res-
olution and sensitivity, such as thin layer chromatography (TLC) –
in a time when the characterization of a lipid proﬁle was limited to
content of entire lipid classes, addressing only a small fraction of
the lipid complexity. With the advent of gas chromatography
(GC) and high performance liquid chromatography (HPLC), the
ﬁeld was pushed forward, until the emergence of mass spectrom-
etry as a sophisticated highly sensitive technology able to further
deconvolute lipid diversity. Over the last decades, enormous pro-
gress occurred in terms of sensitivity and resolution of analytical
techniques [7]. Currently, with combined state-of-art techniques,
it is possible to virtually identify and quantify the whole lipidome
of an organism, cells and organelles [8]. Nonetheless, although glo-
bal lipid proﬁling provides extensive characterization and quantiﬁ-
cation of total lipids, usually extracted from whole cell extracts or
organelles, it provides little information on lipid distribution in the
cells. Lipids are not homogeneously distributed in the cell, and
their synthesis and trafﬁcking are also growing areas of research
[9,10].
Many different organisms have been used in studies of lipid
biology over the years [2,5,11–15], revealing an enormous variety
of lipid structures, with an estimate of several hundred thousandB.V. Open access under CC BY-NC-ND license.
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unanswered on the speciﬁc regulatory mechanisms that generate
and maintain this diversity of molecules. The most fundamental
questions probably are: how do cells sense and adjust their lipid
composition? And what are the roles of these different lipid species
in cell biology and physiology?
This particularly concerns the physiological consequences of an
altered lipid homeostasis. A number of diseases with signiﬁcant
socioeconomic impact (i.e.: obesity, diabetes, atheroschlerosis
and Alzheimer’s disease) have a putative lipid component in their
onset and progress. Hence, understanding the mechanisms that
control changes of lipid patterns is of signiﬁcant diagnostic rele-
vance [17–23].
The major lipid classes in eukaryotes are: glycerophospholipids,
sphingolipids and sterols [5,24]. Amongst phospholipid and sphin-
golipid structures, a remarkable diversity arises from different pos-
sible combinations of head-groups and fatty acids, the latter with
different chain lengths, hydroxylations and degrees and positions
of desaturation.
Noteworthy, lipid metabolism is well conserved among eukary-
otes [2,25] making yeast an advantageous model organism for
studying lipid homeostasis and function. In this review we will fo-
cus on the importance of yeast as a model organism and some of
the innovative advantages for the lipid research ﬁeld.
2. Advantages of using yeast as a model system for lipid studies
Saccharomyces cerevisiae is a powerful model organism for
studying cell biology. Since 1988, when Botstein and others [26]
speculated that yeast would be an ideal model system for modern
biology, its use has increased exponentially, eventually becoming a
reference organism [27]. A few years after the publication of the
complete S. cerevisiae genome sequence [28], a vast set of mutants
was created, with deletion of nearly all open reading frames
[29,30]. Over the years, this yeast has been extensively exploited
in different assays improving our understanding of many diverse
cellular processes, based on DNA microarrays, gene disruptions,
protein localization, protein–protein interactions and functional
analysis by genetic interactions [31–34]. In fact, almost every area
of cell biology has beneﬁted from the use of yeast as a model sys-
tem, rendering S. cerevisiae as the eukaryotic organism with the
best described genetics and metabolism. On the topic of lipids in
cell biology, the availability of genome sequences and the collec-
tion of data on mutants allowed the characterization of genes
and proteins involved in lipid metabolism. But the studies of lipids
in yeast were considerably less prominent than the quick burst of
large scale genetics and proteomics studies. This hurdle was not
due to less appreciation of lipids in cell biology, but rather to tech-
nical limitations, given that methods to analyze lipids were labori-
ous and not very sensitive compared to the available genomics and
proteomics techniques.
As a model system, yeast has many advantages for the study of
lipid biology: (i) convenient experimental tractability, due to sim-
ple growth conditions and facile genetic manipulation compared to
mammalian cells; (ii) yeast can be cultivated in completely deﬁned
medium, allowing a precise control of physical and biochemical
parameters, contrary to mammalian cells which usually grow ro-
bustly using cultivation with serum containing media (lipid rich
media). This is particularly relevant for studying lipid metabolism,
since cells can take up molecules as nutrients and fatty acids from
the media, making the interpretation of phenotypes less clear; (iii)
and the yeast model beneﬁts from a well-curated databases and a
large collection of plasmids and genomic libraries that are avail-
able; and (iv) the high degree of conservation of many fundamen-
tal metabolic pathways between yeast and mammals.Given the fact that lipid homeostasis is critical for cell physiol-
ogy, it is not surprising that lipid metabolic reactions also share a
high degree of conservation in eukaryotes [2,25]. It is important
to note that such similarities are not limited to genetic homology
but they also extend to the general architecture of major meta-
bolic/signaling pathways and regulatory mechanisms, despite
some differences, especially in the input queues and readouts that
must be taken into account [5,35]. Finally, amongst the advantages
of using yeast as a model system to study eukaryotic lipid metab-
olism, there is one key aspect: the simplicity of its lipidome. While
yeast has only a few hundred lipid species [36,37], mammalian
cells have thousands [24,38], and the task of studying lipid homeo-
stasis in yeast is, obviously, greatly simpliﬁed.
As the understanding that lipids are indispensable molecules
for physiology arose, studying the mechanisms that control lipid
homeostasis and function became a signiﬁcant topic in cell biology.
Many detailed reviews on glycerophospholipids, sphingolipid and
sterol metabolism have appeared recently and should be consulted
for more detailed information [2,39,40].
3. Lipids homeostasis and function – studies and different
approaches
The use of yeast as a model system enabled the discovery and
characterization of many genes involved in lipid metabolism. The
enzymes involved in the early steps of sphingolipid pathway, for
example, were all ﬁrst identiﬁed by yeast genetics [41] and then
used to identify the corresponding genes in humans and other
organisms.
In attempting to decipher the pathways that regulate lipid
homeostasis, researchers have used yeast gene deletion collections
in several high-throughput screens, examining the phenotypic ef-
fects of gene loss and gene interactions in lipid metabolism, for
example: systematic analysis of yeast harboring potential defects
in lipid homeostasis [42], a screen that associated sphingolipids
and sterols to cell surface delivery [43], genetic proﬁling of inositol
auxotrophic phenotype [44,45] and screening for players in lipid
droplet formation [46]. The genetic approaches are still proving
to be an enormous aid towards the identiﬁcation and characteriza-
tion of genes associated with lipid metabolism. They normally gen-
erate extensive datasets that can be used as starting points to the
discovery of novel connections between genes and cellular pro-
cesses (Fig. 1). However, it is important to note that these ap-
proaches are rather indirect. Deletion of non-essential genes does
not always cause a phenotype, perhaps due to overlapping func-
tions of paralogous genes or compensatory effects during adapta-
tion. This is of special concern when performing screens with
mammalian cells, given the high number of genes with multiple
paralogs and the complexity of the mammalian lipidome. In an at-
tempt to perform a large-scale screening of protein kinases in-
volved in lipid homeostasis in mammalian cells, Grimard and
others [47] perform a siRNA knockdown of 600 human kinases
combined with TLC analysis of lipids. Despite the limitations of
the approach in terms of sensitivity of lipid proﬁling, the screen
yielded 91 hits with a lipid phenotype, eventually characterizing
JNK2 as a new regulator of triglyceride homeostasis. Now, with
the currently available lipid analytical techniques all the advanta-
ges of yeast as a model system, we believe that the use of yeast-
based large scale screenings related to lipid metabolism will
greatly accelerate our understanding of lipid homeostasis.
Concerning the functional architecture of lipid pathways, S.
cerevisiae was employed to characterize the distribution of en-
zymes involved in lipid metabolism. In a screening using green
ﬂuorescent protein (GFP)-tagged proteins involved in lipid meta-
bolic reactions, Natter et al. [48] described the ER as a central stage
Fig. 1. Different approaches to study lipid homeostasis and function using yeast as a model system. Genes involved in lipid metabolism/regulation have been identiﬁed and
characterized through yeast genetic screens. Lipidomics analysis reveal the global changes of lipid proﬁles in different conditions, and the integration of other ‘‘omics’’
datasets generated from high-throughput yeast based screenings will help to unravel global mechanisms of lipid homeostasis. Expression of human proteins in yeast to create
target-based screens to facilitate discovery of compounds that interfere with lipid homeostasis.
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but they also found a signiﬁcant number of these proteins in other
membrane compartments as mitochondria, Golgi, vacuole and
vesicles.
Apart from understanding the distribution of lipid biosynthetic
machinery in the cell, another key aspect of the study of lipid
homeostasis and function is the pattern of lipid distribution in sub-
cellular compartments. Cells synthesize a large variety of lipids, the
vast majority of which is made at the ER and further translocated
to speciﬁc compartments. Using cell fractionation techniques,
characterization of subcellular membranes has been accomplished
[49,50], and, although some mechanisms of membrane trafﬁcking,
inter-organellar contact sites and vesicular and non-vesicular
transport have been proposed to account for this heterogeneity
in lipid distribution [51–54], the dynamic nature of the differential
lipid composition is still far from being understood.
4. Lipid visualization
The role of most lipid species in cellular membranes is thought
to be mainly as passive structural components or for speciﬁc lipid
species as factors involved in recruitment of soluble proteins to
membranes. While the early models of cellular membranes were
oversimpliﬁed representations of the lipid bilayer, it is now known
that cellular membranes are composed of an enormous variety of
lipid structures and proteins that are non-randomly distributed.
The observations that sterols and sphingolipids have the capacity
to partition together in the plasma membrane with speciﬁc pro-
teins have raised the possibility of the existence of membrane mi-
cro domains, formally hypothesized as lipid rafts [55]and/or lipid
shells [56], platforms in the plasma membrane that are proposed
to be enriched in sphingolipids, sterols and proteins. The underly-
ing molecular concept of the raft hypothesis is that the interaction
of sphingolipids and sterols is favored by their physical properties
and creates lateral heterogeneities in the membrane, driving the
appearance of ordered/disordered domains. The raft hypothesis
has been revisited many times in the last 20 years [57–59]. Yet,
the proof for the existence of rafts and their dynamic assembly
in the biological context has been a target of dispute [60–62] and
despite all the efforts, the important question - whether lipid rafts
play a role as physiologically relevant entities – still remains vague.
The lipid shell hypothesis postulates that protein transmembranedomains show speciﬁc interaction with lipids and these lipids have
low afﬁnity interactions with other lipids organizing a lipid shell of
distinct composition around membrane proteins [56]. Molecular
dynamics studies [63] seem to support the basic tenant of this
hypothesis. If protein–protein interactions were to occur this could
lead to a structure that would be very difﬁcult, is not impossible, to
differentiate from that proposed in the lipid raft hypothesis.
Controversies in the ﬁeld, however, stimulated interest and
prompted progress in development of techniques to allow the
study of these domains, eventually contributing to our understand-
ing of membrane dynamics. With the development of high tempo-
ral and spatial super resolution microscopy, it was shown that both
proteins and lipids are not freely moving in the membrane, but
that their diffusion is occasionally restricted in speciﬁc domains
[64,65]. These experiments use single particle tracking, which is
visualized generally in two dimensions by the available tech-
niques. Potential problems with these experiments stem from
the fact that most cell surfaces are not ﬂat and that movement in
the z-axis is therefore not efﬁciently detected [66]. Therefore, there
is still a high level of skepticism in the ﬁeld that is partially due to
the lack of tools to visualize these domains in vivo and partially
due to the lack of direct functional evidence that these domains ex-
ert an effect on signaling pathways and cell physiology in general.
The challenge of visualizing lipids remains difﬁcult because of the
limited availability of appropriate probes to visualize naturally
occurring lipids in the living cell context. Lipid-binding proteins,
such as lysenin [67] and cholera toxin [68] have been used to study
membrane domains, but they provide little information about the
lipid composition and structure of these domains. More speciﬁc
probes used to study lipid domains comprise analogues of sterols
[69], phospholipids [65] and ﬂuorescent tagged proteins. However,
ﬂuorophores usually have an enormous impact on the behavior of
the lipid as shown by differential partitioning of the cholesterol
ﬂuorescent analogue dehydroergosterol (DHE) and 25-NBD-cho-
lesterol, which localize preferentially to liquid ordered and disor-
dered domains, respectively [69].
A promising tool to study the distribution of lipids in the cell is
the development of antibodies against speciﬁc lipids. Antibodies
against the lyso(bis)phosphatidic acid (LBPA) [70] phosphatidyl-
glucose [71], ceramides [72], and even an antibody that recognizes
ceramide/cholesterol enriched domain have been described [73].
Novel technologies are currently being developed using yeast as
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cally bind sphingolipids [74,75]. This will putatively allow the visu-
alization of speciﬁc lipids in the cellular context, massively
improving our understanding of membrane organization and intra-
cellular trafﬁcking.
5. Intracellular trafﬁcking
Eukaryotic cells have a highly complex system of intracellular
trafﬁcking. Proteins and most of lipids are synthesized and ma-
tured in the ER and Golgi and further transported to different sub-
cellular compartments and to the cell surface, ultimately affecting
global membrane composition. Endocytosis also plays a role in the
plasma membrane composition, by selective internalization of
membrane patches in the form of endosomes, which will eventu-
ally follow different routes to degradation or recycling [76,77].
By controlling the composition of plasma membrane, cells regulate
their ability to respond to their environment, in processes includ-
ing nutrient uptake, intercellular signaling and morphogenesis.
Intracellular trafﬁcking is a highly conserved process between
yeast and mammals, and studies in yeast have largely contributed
to the identiﬁcation and characterization of genes involved in the
secretory [78] and endocytic pathways [79], which, later on, al-
lowed their mammalian homologues to be characterized [77].
Yeast research still promotes critical advances in the intracellular
trafﬁcking ﬁeld, especially with regard to the regulatory mecha-
nisms that govern this machinery. Of special interest, is the collec-
tion of mutants defective in secretory, vacuolar and endocytic
pathways [80]. Intracellular trafﬁcking has long been studied from
the protein perspective, but more recently, lipids have emerged as
equally important players in this process. In yeast, the delivery of
many plasma membrane proteins requires the proper synthesis
of sphingolipids and sterols [81]. Based on studies showing the
presence of plasma membrane proteins in detergent-resistant
membrane fractions [82], a mechanism of protein-lipid delivery
has been proposed suggesting that membrane protein sorting oc-
curs in the trans-Golgi network in parallel with lipid sorting – pref-
erentially with sphingolipid and sterols – generating an
enrichment of those lipids in the plasma membrane [10,83].
Lipids are not just involved in trafﬁcking as platform compo-
nents, they also have a critical role in protein remodeling during
their maturation process towards the plasma membrane. The
transport of GPI-anchored proteins to the plasma membrane is a
good example of the roles of lipids in the intracellular trafﬁcking.
GPI-anchored proteins are synthesized in the ER and further sub-
mitted to remodeling of their lipid moiety before transport to Gol-
gi. During the remodeling, the initial glycerophospholipid moiety is
replaced by a ceramide structure or very long chain saturated diac-
ylglycerol [84], an important step in concentration into ER-exit
sites for the formation of GPI-anchored protein containing vesicles
[85]. Despite some differences between yeast and mammals con-
cerning the precise structures and the location of the remodeling,
there is good evidence of the conservation of the cellular strategy
for accomplishing this process. A recent study on mammalian cells
also showed that interventions at the multiple steps of GPI-an-
chored protein synthesis and remodeling differentially affect the
levels of glycosphingolipids, suggesting that the transport of very
long chain ceramides from ER to Golgi is coordinately regulated
by the metabolism of GPI-anchored proteins [86].
Another example of the role of lipids in intracellular trafﬁcking
comes from the trans-Golgi vesicular transport. Phosphatidylinosi-
tol-transfer proteins (PITPs) are highly conserved proteins that
mediate the transfer of phosphatidylinositol or phosphatidylcho-
line monomers between membranes. It was through yeast genetics
that the ﬁrst insights into the biological role of PIPTs came to light.
In yeast, the major PIPT is encoded by the essential SEC14 gene,which is necessary for the protein transport from the Golgi via
vesicular trafﬁcking [87]. Basically, the physiological function of
Sec14p is to coordinate PI and PC metabolism, generating an ade-
quate lipid environment in Golgi membranes that is permissive
to vesicle biogenesis. The dysfunction of Sec14p not only impairs
protein trafﬁcking in the trans-Golgi, but it also deranges lipid
metabolism in general, eventually affecting the biogenesis of secre-
tory vesicles [88]. Subsequent, studies in mammalian cells have
demonstrated that dysfunctional PIPTs are of great medical inter-
est, as they lead to neurodegenerative processes, defects in nutri-
ent absorption and glucose homeostasis [89].
6. Lipid asymmetry
One important aspect of membrane composition in cell biology
is the lipid asymmetry. Sphingolipids and phosphatidylcholine (PC)
are mainly found in the exoplasmic leaﬂet, whereas the amino-
phospholipids phosphatidyl serine (PS) and phosphatidyl ethanol-
amine (PE) are mainly found in the cytoplasmic leaﬂet. This
differential distribution of phospholipids in the two leaﬂets of
the plasma membrane is crucial for cellular processes such as
polarization during cell budding and mating in yeast [90] and the
internalization step of endocytosis [91]. The enzymes responsible
for the translocation of phospholipids from the outer to the inner
leaﬂet of the plasma membrane in yeast belong to the type 4 sub-
family of P-type ATPases [91], and two of them, Dnf1 and Dnf2,
were recently shown to govern phospholipid ﬂipping with Cdc50,
by regulating the activity of Cdc42 – a highly conserved protein
that regulates cellular morphogenesis [92]. Interestingly, sphingo-
lipid homeostasis also seems to be involved in this dynamic control
of phospholipid distribution, by indirect control of Fpk1, a kinase
that stimulates the activity of the ﬂippases [93].
We are just starting to understand how a eukaryotic cell con-
trols these dynamic changes at the plasma membrane in order to
maintain the proper balance among the different lipids.
7. Functional interaction – ergosterol and sphingolipids – one
good example
It is likely that lipids often function collectively rather than as
single molecules in the cell. This is evidenced by the interconnec-
tion in the lipid biosynthetic and degradation pathways - through
the use of commonmetabolic substrates and/or intermediates [94],
giving place to the conception of a highly dynamic and intercon-
nected network [95,96]. It is clear now that studies in lipid metab-
olism must be conceived and interpreted in a global manner, as
interventions in one pathway can have secondary effects in other
classes.
The relationship between different lipid classes have been long
discussed in terms of membrane structure, controlling the ﬂuidity
and preferential association of different lipids that would facilitate
the emergence of membrane domains (argued to be important for
activity of membrane associated proteins). It was only recently,
however, that the functional relationship of different lipid classes
was proven. The study of Guan et al. [97] is themost convincing evi-
dence of a functional interaction of sphingolipids and sterols. Using
an unbiased lipidomics analysis of mutants with gene deletions in
late steps of ergosterol biosynthesis, it was shown that deletions
of ERG genes led to the absence of ergosterol and accumulation of
the corresponding metabolic intermediates. But most remarkable
was the observation of dramatic changes in the sphingolipid com-
position of these ergmutants. One important lesson from this study
is the observation that cells can sense the presence of aberrant ste-
rol structures and adapt their sphingolipid composition accord-
ingly, most likely in an attempt to maintain important cellular
functions (Figure 2). One example showing that interruption of this
Fig. 2. Regulation of lipid homeostasis. Changes in membrane ﬂuidity or curvature
are perceived by cells and translated into pathways to induce compensatory
changes in the lipid proﬁle. The lipid proﬁle is also affected by nutritional status and
abiotic stresses, such as temperature and osmolarity. Adaptive changes occur via
genetic and biochemical mechanisms, and changes in the lipid proﬁle also alter the
capability of cells to respond to external stimuli.
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erg2scs7 double mutant to grow in the presence of inhibitors of
the TORC1 signaling pathway, such as caffeine and rapamycin, de-
spite normal TORC1 signaling activity [98].
Many questions remain open after this study: how do cells
sense and control their lipid composition? Which are the molecu-
lar sensors that signal the alterations in membrane lipid composi-
tion to trigger the changes in lipid abundance? How is this process
controlled?
Recent studies in yeast have shed some light on the mecha-
nisms of control of sphingolipid biosynthesis. It was known that
the TORC2 complex, and the associated proteins Slm1/2, exerts
part of their functions in cell growth through the regulation of
the sphingolipid pathway [99,100]. Recently, a feedback mecha-
nism was discovered that controls sphingolipid metabolism
[101]. Two homologous proteins – called Orm1p and Orm2p, have
been characterized as negative regulators of the enzymatic activity
of serine palmitoyl transferase, the ﬁrst committed step in the syn-
thesis of sphingoid bases. The Orm proteins are regulated by a pro-
tein kinase cascade that involves the Ypk1 kinase [102].
Subsequently, bridging the knowledge that sterol mutants with al-
tered sphingolipid composition have decreased TORC2 activity, it
was proposed that TORC2 signaling involves a lipid homeostatic
control [103]. In an elegant series of experiments, it was shown
that Slm1/2 proteins, which are sequestered on eisosomes during
exponential growth, leave eisosomes upon membrane stresses
(either mechanical or induced by inhibition of SL biosynthesis) to
associate with and activate TORC2 complex. TORC2, in turn, phos-
phorylates Ypk2p which phosphorylates the Orm proteins. This re-
vealed a homeostatic mechanism in which TORC2 signaling
pathway responds to membrane stresses, possibly by sensing plas-
ma membrane curvature at eisosomes, and mediates compensa-
tory changes in lipid synthesis.
8. Lipid homeostasis – lipid sensors
Sterols are not evenly distributed in all cellular compartments.
They are synthesized in the ER and distributed towards the plasma
membrane, where their concentration is increased. Understanding
the processes that govern sterol distribution in the cell is of great
interest, as its levels in the plasma membrane are critical for vital
processes, such as endocytosis and most likely in creating an efﬁ-
cient membrane barrier. Clearly, cells maintain the levels of sterols
in themembrane under tight control, and the imbalance in this pro-cesses can lead to several dysfunctions [97,104]. Oxysterol binding
proteins are a well conserved family of protein from yeast to man,
that are considered putative sterol sensors and regulators of sterol
distribution in the cell. The characteristic of this family is the pres-
ence of a ligand binding domain that accommodates different ster-
ols. In yeast, the OSH family is composed of seven members (OSH1-
OSH7). Deletion of all OSHproteins is lethal, but expression of any of
the seven isoforms restores cell viability [105]. Some of these pro-
teins contain pleckstrin homology domains, are membrane associ-
ated and are enriched at membrane contact sites, i.e. junctions of
ER with other organelles, where they supposedly perform their
function of sterol transfer between organelles [53] as well as an-
other function as regulators of phosphoinositide metabolism [106].
9. Phosphatidic acid and the regulation of phospholipid
biosynthesis
Concerning phospholipids, the scenario is not less complicated.
Cells have hundreds of different phospholipids that are distributed
over all the cellularmembranes. Phospholipid biosynthesis relies on
a sophisticated regulatory circuitry, that involves nutrient sensing,
lipid-protein interactions and transcriptional regulation of genes
involved in the biosynthetic pathways of different phospholipids
[40]. A few years ago, it was reported that the phospholipid phos-
phatidic acid (PA) has a central role in phospholipid homeostasis
[107]. PA itself is a central metabolite in the phospholipid metabo-
lism, being a precursor for most phospholipids [40]. Its mode of ac-
tion involves the associationwith the transcription repressor Opi1p,
which is bound to the ER membrane via association with Scs7p.
Opi1 localization is however dependent on intracellular inositol
levels, which in turn control PA availability. Opi1p controls the
expression of many genes in phospholipid metabolism, and it is
likely that this regulatory circuitry controls phospholipid metabo-
lism inmany different conditions [108]. Recently, it was shown that
the lipid-protein interaction between Opi1p and PA is inﬂuenced by
pH, altering the electrostatic properties of the lipid, which is recog-
nized by the effector [109]. Despite this fundamental discovery
unveiling a global transcriptional control on a variety of phospho-
lipid biosynthetic enzymes, many questions still remain on the
topic andmany other regulatory pathways are yet to be discovered.10. Protein lipid interactions
In order to understand the function of cell membranes and bio-
logical processes performed by membrane proteins, it is funda-
mental to understand how the lipid composition affects protein
folding, enzymatic and other activities. To address these questions,
we need detailed information about the lipid environment in
which these proteins are inserted [110]. One recent attempt to un-
ravel protein-lipid interactions was a screening done with S. cere-
visiae to catalog these interactions [111]. They developed
nitrocellulose arrays that contained sets of lipids of the main lipid
classes in yeast and determined the binding proﬁles of soluble pro-
teins. Several novel interactions were reported, many of which
could not be inferred from canonical lipid-binding domains, indi-
cating that our understanding of lipid-protein interaction is still
on its infancy.11. Maintenance of lipid homeostasis
One of the major challenges in the assessment of the roles of
lipids in cell biology is the diversity of lipid molecules and the
variety of cellular processes that can be affected by lipids. Only a
few studies have described the changes of lipids under different
environmental conditions or drug treatments in a systematic way
A.X.S. Santos, H. Riezman / FEBS Letters 586 (2012) 2858–2867 2863[50,112] and the lack of standardized protocols for lipid extractions
and lipid annotation makes the comparison of such studies very
difﬁcult.
The cell’s lipid composition is maintained by coordinated path-
ways of synthesis, distribution and degradation of phospholipids,
sphingolipids and sterols [5,113,114]. These interconnected net-
works constitute a highly dynamic biological core that allows cells
not only to adapt their lipid proﬁle to environmental challenges
such as heat stress, osmotic stress and nutrient availability [115–
119], but also to sense the levels of the different lipids and adjust
their lipid composition to preserve cellular functions (Fig. 2) [97].
The importance of a lipid homeostasis at the systemic level is dem-
onstrated by the fact that many important diseases such as obesity,
diabetes, atheroschlerosis and Alzheimer’s disease have a lipid
component postulated to affect their onset and/or progression.
Even though the physiological consequences of an altered lipid
homeostasis have gained more attention the regulatory mecha-
nisms involved in the control of the lipid proﬁle of a cell or an
organism are still largely unknown [16–20].
As a model system for understanding lipid homeostasis, S. cere-
visiae allows for more detailed study of the underlying molecular
mechanisms compared to what can be carried out in isolated hu-
man cells. With the ease of manipulation, yeast is an ideal model
to study regulatory networks, where the system as a whole needs
to be considered.
12. Drug screens
S. cerevisiae is currently the best characterized model organism
to monitor drug sensitivity [120]. Despite being a simpliﬁed model
as compared to mammalian cells, it still provides a biologically in-
tact system, in which the different cellular effects of a chemical
compound can be assessed in the context of a living cell (Fig. 1).
Yeast is particularly well suited for high throughput methods be-
cause of its short life cycle, growth in liquid or solid media, without
elaborate technical restrictions or expensive media. For drug
screening approaches, yeast is probably themost convenient model
organism to assess the effects of different compounds on proteins
and pathways in a genome-wide scale [121,122]. Maybe the most
valuable feature of yeast as a system for drug screenings is the pos-
sibility to express human protein homologs in yeast, making it valu-
able tool for drug discovery. A recent yeast-based assay identiﬁed
drugs active against human mitochondrial disorders [123].
Ceramides and sphingolipids play fundamental roles in cell
biology and have been implicated in different types of cancers.
Many efforts have been applied to explain the role of ceramides
and sphingolipids in normal and diseased cells, but intervening
in ceramides biosynthesis in humans can be challenging, as there
are six different ceramides synthases (CerS), each of which has a
different speciﬁcity to the length of the fatty acyl coenzyme A they
use as substrate [124]. The CerS are differentially distributed in
various tissues, indicating that different subsets of ceramides could
be made in speciﬁc tissues to meet speciﬁc physiological needs
[125]. Despite all the efforts to characterize these enzymes, much
remains to be understood about the precise roles of the different
ceramides and sphingolipids made by each of the CerS. The use
of speciﬁc drug inhibitors would greatly facilitate the study of each
of these enzymes, but the available inhibitors against CerS (Fumon-
isin B, Australifungin) are rather unspeciﬁc towards the different
homologs. In two recent studies, the yeast ceramides synthases
(LAG1 and LAC1) were replaced by each of the human CerS, retain-
ing their speciﬁcity [126,127]. This is an ideal situation for screen-
ing drug inhibitors against CerS. By a high throughput comparative
screening, it should be possible now to test and identify com-
pounds that speciﬁcally inhibit each of the enzymes [74].Chemical genomics is also a valuable approach to study the
mechanism of action of bioactive chemicals that may have human
therapeutic signiﬁcance [121,128]. In the particular case of lipid
metabolism, two successful studies were designed in yeast and
uncovered important connections of the dysfunctional processes
and lipid biosynthesis. The inhibitor of cancer cell invasion, dihy-
dromotuporamine C (dhMoTC), was ﬁrst discovered in a pheno-
typic screen for small molecules that inhibited invasion of
carcinoma cells. Because of the difﬁculties of identifying the target
of this drug, the authors relied on a genome-wide drug-induced
haplo insufﬁciency screening to identify its mode of action, which
was eventually shown to target sphingolipid biosynthesis
[129,130]. Another promising example for the use of yeast screen-
ings to unravel pathological mechanisms of actions, was the iden-
tiﬁcation of fatty acid elongases as essential players to cope with
alpha-synuclein toxicity – a hallmark of Parkinson’s disease [131].
13. Lipidomics – advances and challenges
It is clear now that studies in lipid metabolism must be con-
ceived and interpreted in a global manner, as interventions in
one pathway can have effects in other lipid classes. In this sense,
the emergence of lipidomics was of vital importance to study lipid
homeostasis and function. The recent technical advances have
empowered us to perform global lipid analysis. Although it is still
not possible to quantitatively analyze all lipid species at once,
many different methods are available, offering high sensitivity
and resolution for global lipid proﬁling [132,133]. The modern ap-
proaches for lipid analysis are dominated by mass spectrometry,
commonly ESI-MS combined with a previous separation by liquid
chromatography or gas chromatography to satisfy the demands
for speciﬁc solutions given the structural diversity of lipids. MALDI
is another ionization technique suitable for lipid analysis, and un-
like ESI, it can analyze the analyte directly from the solid phase, i.e.
TLC plates [134]; or directly from tissue sections, in imaging mass
spectrometry [135], or directly from isolated organelles [8].
In lipidomics, the mass spectrometry approach is used not only
for qualitative, but also for quantitative analysis, which can be
either relative or absolute, depending on the method. Global lipi-
domics (shotgun lipidomics) usually performs relative quantiﬁca-
tion, while targeted approaches as MRM-MS allow for
quantitative analysis of speciﬁc lipid species. Absolute quantiﬁca-
tion of lipids, however, is dependent on the availability of internal
standards, which are still few. Ideally, internal standards should be
structurally similar to the analyte (i.e. a stable isotopically labeled
version); however, this is not practical for lipidomic analysis and
usually a mix of selected representatives of lipid classes is used.
The yeast global lipidome have been elucidated by different
groups [36,37]. Despite a few characterization studies of lipidomic
changes over a range of environmental conditions, to date, there is
no comprehensive catalog of how cells adapt their lipidome to dif-
ferent environmental conditions [50,112]. One of the major future
challenges for lipidomics will be the interpretation of the enor-
mous datasets with complex lipid proﬁles that are emerging from
lipidomic studies (Fig. 2). Undoubtedly, there are many potentially
interesting lipid patterns, and therefore, advances in computa-
tional and statistical approaches is of vital importance [136].
14. Mathematical modeling
Some attempts have been made to develop mathematical mod-
els of the metabolic ﬂuxes of lipid metabolism, using S. cerevisiae as
the model system. The most comprehensive examples come from a
studies on sphingolipid metabolism [137–139] that successfully
described the metabolic reactions in accordance with available
2864 A.X.S. Santos, H. Riezman / FEBS Letters 586 (2012) 2858–2867data about gene expression levels, kinetic properties of the en-
zymes and metabolite concentrations, being further implemented
in genome-scale metabolic model [140].
The development of these models based on organisms like yeast
is an advantageous strategy since the models are simpler and, once
validated, can be translated into more complex systems, such as
mammalian cells. The use of these models will help researchers
to test different scenarios of perturbation in the system, leading
to potentially interesting insights into points of regulation.
Finally, due to the availability of different high throughput data-
sets such as from transcriptome [141], proteome [142], phospho-
proteome [143], metabolome [144] and interactome [145]
analysis S. cerevisiae is the model organism with the most compre-
hensive experimental dataset available (Fig. 2).
In the future, yeast lipidomics will add a fundamental piece to
this cell biology puzzle. The complexity of lipid metabolism in-
volves several layers of regulation, and efforts need to be done in
order to integrate different experimental data into single models
that provide a detailed description of cellular processes. An over-
whelming amount of information is available now about lipids
and lipid metabolism. At this time, however, there is no yeast data-
base that combines results from multiple lipidomics methods in a
harmonious way, nor a database that systematically collects anno-
tated information related to lipids, similar to existing databases for
proteins and genes.
15. Final considerations
The current research on lipids is now shifting from molecular
characterization of lipid structures to a global understanding of dy-
namic lipid changes in a cellular/organismal context in response to
intracellular cues and extracellular challenges. And as for other
areas of cell biology, studies in yeast have greatly contributed to
the study of lipid homeostasis and function, yielding major insights
into fundamental pathways that could be transferred to more com-
plex organisms [4].
It is clear that lipidomic analysis is a powerful tool to be used
not only as a characterization method, but also as a discovery
method. By combining genetic screens, different environmental
conditions and the assessment of lipid changes under multiple par-
allel conditions, we will be able to uncover many unsuspected and
novel associations of genes, proteins and lipids.
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